Massive stroke
Searched over 200M research papers for "massive stroke"
Summary
10 papers analyzed
These studies suggest that various factors such as clinical, radiological, and metabolic variables, newer therapies, inflammation levels, and surgical interventions influence the outcomes and prognosis of massive stroke patients.
Not a yes or no question
To use the Consensus Meter, try asking a simple yes or no question
Research summarized with Copilot
Beta20 papers analyzed
Understanding Massive Stroke: Predictors, Outcomes, and Treatment Strategies
Introduction to Massive Stroke
Massive ischemic stroke, characterized by severe neurological impairment, poses significant challenges due to its high mortality and morbidity rates. This article synthesizes recent research to highlight the predictors, outcomes, and treatment strategies for massive stroke.
Predictors of Massive Stroke
Clinical and Radiological Predictors
Massive ischemic stroke is often associated with specific clinical and radiological factors. Key predictors include a cardio-embolic stroke mechanism, unknown stroke onset, early ischemic findings on neuroimaging, and arterial occlusions on acute imaging. Additionally, lower hemoglobin concentration and higher white cell count are significant metabolic predictors.
Inflammation and Stroke Outcomes
Persistent inflammation has been identified as a critical factor influencing short-term outcomes in massive stroke patients. Higher baseline inflammation levels, indicated by the neutrophil-to-lymphocyte ratio and blood glucose concentrations, predict poor short-term prognosis, increased mortality, and higher incidence of pulmonary infections.
Outcomes of Massive Stroke
Short-Term and Long-Term Outcomes
The prognosis for massive stroke patients varies. Approximately 28% of patients achieve a favorable outcome, which is associated with factors such as lower age, previous cerebrovascular events, hypolipemic pretreatment, lower acute temperature, lower glucose levels at 24 hours, and arterial recanalization. However, persistent inflammation and high baseline inflammation levels are linked to worse short-term outcomes and higher mortality rates.
Surgical Interventions
External decompression, or hemicraniectomy, is a life-saving surgical intervention for patients with massive cerebral infarction. Despite a high mortality rate, this procedure can significantly improve the quality of life for survivors, even those with dominant hemisphere strokes. Early decompressive hemicraniectomy is generally favored by young adults, although a substantial minority may be reluctant to undergo such aggressive treatment.
Treatment Strategies for Massive Stroke
Reperfusion Therapies
Rapid access to reperfusion therapies remains the cornerstone of stroke care. These therapies are critical for reducing mortality and improving functional outcomes.
Advanced Therapeutic Approaches
Recent advances in stroke management include osmotic therapy, hypothermia, maintained normothermia, strict glycemic control, induced hypertension, and hemicraniectomy. These interventions require a high level of expertise and meticulous medical management.
Noscapine as a Potential Treatment
Noscapine, a bradykinin antagonist, has shown potential in reducing mortality rates in massive ischemic stroke patients. Although statistical significance was not achieved, a reduction in mortality rate by 16% in Noscapine recipients suggests the need for further studies with larger sample sizes.
Conclusion
Massive ischemic stroke is a severe condition with complex predictors and varied outcomes. Understanding the clinical, radiological, and metabolic predictors can help in early identification and management. Advanced therapeutic strategies and surgical interventions, along with potential new treatments like Noscapine, offer hope for improving outcomes in massive stroke patients. Continued research and specialized care are essential for optimizing treatment and reducing the burden of this devastating condition.
Sources and full results
Most relevant research papers on this topic
